• CCL7+ Macrophages Mediate Immunotherapy Resistance in CRC

  2026-05-07

  Chen et al. (2025) reveal that CCL7-expressing tumor-associated macrophages (TAMs) drive resistance to immune checkpoint inhibitors in colorectal cancer by modulating immune cell infiltration and metabolic programming. Their mechanistic dissection highlights CCL7 as a promising therapeutic target to enhance immunotherapy efficacy in CRC.

• Human iPSC Lines from Psychiatric Disorder Patients: A New M

  2026-05-07

  This study presents the generation and comprehensive characterization of human induced pluripotent stem cell (iPSC) lines derived from two cousins with schizophrenia and bipolar disorder and their unaffected cousin. These patient-specific iPSCs provide a valuable platform for investigating neurodevelopmental mechanisms and for future drug screening in psychiatric research.

• HyperScript First-Strand cDNA Synthesis Kit: Precision in Co

  2026-05-06

  The HyperScript First-Strand cDNA Synthesis Kit enables high-fidelity cDNA generation from challenging RNA templates, such as those with strong secondary structures or low transcript abundance. Its advanced enzyme design and primer versatility empower robust gene expression analysis, even in demanding workflows like qPCR or rare transcript detection.

• LL-37 and Truncated Peptides: Selective Antibiofilm Actions

  2026-05-06

  This study investigates how the human host defense peptide LL-37 and its truncated mimetics, KE-18 and KR-12, act against biofilms and planktonic forms of major pathogens. By distinguishing their selective biocidal and antibiofilm properties, the research advances our understanding of peptide-based antimicrobial strategies for device-related infections.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor Benchmar

  2026-05-05

  Oseltamivir acid is a validated influenza neuraminidase inhibitor that blocks viral replication and inhibits cancer metastasis models. Its solubility, mechanism, and resistance profile make it essential for influenza antiviral research and translational workflows.

• Minoxidil Sulphate in Vascular Biology: Assay Optimization &

  2026-05-05

  Minoxidil sulphate, a potent potassium channel opener, streamlines advanced vascular and hair growth research thanks to its high purity and solubility profile. This article details experimental workflows, data-driven protocol parameters, and troubleshooting strategies, translating leading-edge findings into practical lab advantages.

• APEX2 Is Essential for TERT Expression in Human Stem Cells

  2026-05-04

  This study uncovers a novel role for the DNA repair enzyme APEX2 in regulating telomerase reverse transcriptase (TERT) expression in human embryonic stem cells and melanoma cells. The findings reveal mechanistic links between DNA repair, repetitive DNA elements, and telomerase regulation, offering new directions for research in stem cell maintenance, aging, and cancer.

• Tunable Human Intestinal Organoids: Balancing Renewal and Di

  2026-05-04

  This study presents an optimized human intestinal organoid system that enables precise control of stem cell self-renewal and differentiation without artificial niche gradients. By employing small molecule pathway modulators, the researchers achieved both high proliferative capacity and increased cellular diversity, enhancing the organoid platform's scalability for disease modeling and high-throughput applications.

• Pomalidomide (CC-4047): Mechanistic Depth and Translational

  2026-05-03

  This in-depth article explores how Pomalidomide (CC-4047) is unlocking new frontiers in hematological malignancy research, with a focus on its mechanistic foundation, robust experimental evidence, and strategic applications in translational workflows. Drawing on the latest mutational landscape studies, we provide actionable guidance and protocol benchmarks for researchers navigating the complexities of multiple myeloma and erythroid progenitor cell assays. The analysis is grounded in rigorous literature and bridges product intelligence with workflow optimization, offering a thought-leadership perspective that extends beyond conventional vendor resources.

• Polystyrene Microplastics Drive DDIT4-Linked Kidney Toxicity

  2026-05-02

  This study reveals that 1 μm polystyrene microplastics (PS-MPs) induce nephrotoxicity by activating DDIT4-mediated autophagy and apoptosis in human kidney organoids. These insights clarify the molecular pathways of microplastic-induced renal damage and highlight DDIT4 as a potential target for mitigating toxicity.

• Acifran: Selective GPR109A/B Agonist for Lipid Metabolism Re

  2026-05-02

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) is a well-characterized, selective agonist of HM74A/GPR109A and GPR109B, central to lipid metabolism research. Its defined mechanism enables targeted studies of lipid signaling pathway modulation and metabolic disorder research.

• Preserving Phosphorylation Fidelity: Strategy & Science for

  2026-05-01

  This thought-leadership article explores the mechanistic importance and translational impact of protein phosphorylation preservation. Drawing on recent evidence, innovative workflows, and scenario-based solutions, it provides actionable guidance for researchers seeking high-fidelity signaling data. APExBIO's Phosphatase Inhibitor Cocktail 1 (100X in DMSO) is highlighted as a next-generation tool, with best-practice protocols, a critical review of the competitive landscape, and a forward-looking appraisal of the field’s trajectory.

• ABT-199 (Venetoclax): Precision in Apoptosis Assays for Hema

  2026-04-30

  Harness the exceptional selectivity of ABT-199 (Venetoclax) to dissect the mitochondrial apoptosis pathway in non-Hodgkin lymphoma and AML models. This guide delivers evidence-backed workflows, troubleshooting tactics, and protocol parameters that maximize reproducibility and minimize off-target effects—empowering your hematologic malignancy research.

• Phosphatase Inhibitor Cocktail 2: Precision in Protein Phosp

  2026-04-30

  Phosphatase Inhibitor Cocktail 2 (100X in ddH2O) from APExBIO empowers researchers to reliably preserve protein phosphorylation during complex workflows, ensuring faithful signal transduction analysis. This guide delivers actionable protocols and troubleshooting strategies, translating bench challenges into reproducible, high-fidelity data.

• Rapamycin (Sirolimus): Precision mTOR Inhibition for Cell As

  2026-04-29

  Rapamycin (Sirolimus) is the gold-standard tool for dissecting mTOR-regulated cellular processes, with proven utility from cancer biology to mitochondrial disease models. This article delivers hands-on workflow enhancements, troubleshooting strategies, and cross-domain insights—grounded in real data—to help researchers extract maximum value from APExBIO’s high-purity Rapamycin.

407 records 16/28 page Previous Next First page 上5页 1617181920 下5页 Last page